Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : NIDB-3101
Therapeutic Area : Neurology
Study Phase : Preclinical
Recipient : InSysBio
Deal Size : Undisclosed
Deal Type : Collaboration
InSysBio Announces Its Collaboration with Discoveric Bio Alpha
Details : The collaboration aims to advance the NIDB-3101, which is being evaluated for the treatment of Alzheimer’s disease.
Product Name : Undisclosed
Product Type : Antibody
Upfront Cash : Undisclosed
March 19, 2025
Lead Product(s) : NIDB-3101
Therapeutic Area : Neurology
Highest Development Status : Preclinical
Recipient : InSysBio
Deal Size : Undisclosed
Deal Type : Collaboration